Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04760717 · ClinicalTrials.gov registry record · Phase 2
Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
A Phase 2 study of Ischemic Stroke and Intracerebral Hemorrhage, sponsored by Yale University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 5
- Study locations
NCT04760717: Recruiting Phase 2 study of Ischemic Stroke and Intracerebral Hemorrhage, sponsored by Yale University.
NCT04760717 is a Phase 2 study of Ischemic Stroke and Intracerebral Hemorrhage that is actively recruiting participants, run by Yale University. The registered enrollment target is 200 participants, below the 1,461-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04760717, a Phase 2 study of Ischemic Stroke and Intracerebral Hemorrhage, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this research study is to determine whether blood pressure treatment regimens with spironolactone are better than blood pressure treatment regimens without spironolactone at lowering blood pressure in stroke survivors.
Primary Outcome
The average home systolic blood pressure will be measured using a home blood pressure cuff
Conditions Studied
Interventions
- DRUG Spironolactone Pill
Study Locations (5)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Temple University Hospital - Philadelphia
Connecticut
- Yale New Haven Hospital - New Haven
North Carolina
- Wake Forest Baptist Health - Winston-Salem
Texas
- University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-03-19 |
| Est. Completion | 2025-12 |
| Phase | Phase 2 |
What NCT04760717 shows while recruiting
NCT04760717 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,461-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Spironolactone Pill is the first listed.
NCT04760717 lists 5 locations in 4 states (Pennsylvania, Connecticut, North Carolina).
Frequently Asked Questions
What is clinical trial NCT04760717 about?
NCT04760717 is a clinical study titled "Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke". The purpose of this research study is to determine whether blood pressure treatment regimens with spironolactone are better than blood pressure treatment regimens without spironolactone at lowering blood pressure in stroke survivors.
What is the current status of trial NCT04760717?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2021-03-19. Estimated completion is 2025-12.
What conditions does trial NCT04760717 study?
This clinical trial studies the following conditions: Ischemic Stroke, Intracerebral Hemorrhage, Spironolactone.
What interventions are being tested in trial NCT04760717?
The interventions under investigation include: Spironolactone Pill (DRUG).
Who is sponsoring clinical trial NCT04760717?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04760717 being conducted?
This trial has 5 study locations across Connecticut, North Carolina, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04760717's enrollment target sits among peer trials
200 23rd of 66 higher than 44 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Strategy for Improving Stroke Treatment Response
RECRUITING · Phase 2
-
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
RECRUITING · Phase 2
-
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
RECRUITING · Phase 2
-
Dietary Nitrate Supplements and Ischemic Stroke Recovery
COMPLETED · Phase 2
-
Mayo Acute Stroke Trial for Enhancing Recovery
COMPLETED · Phase 2
-
Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI